
Knowing we have strains of C. acnes that are symbiotic in nature, companies and scientists can create products to target and help curate our skin biomes.
Recent research shows that a strain of C. acnes defendens—dubbed XYCM42—might be the leading candidate for a legitimate skin probiotic. What does that mean for skin care/skin biome innovation?